Literature DB >> 21167544

XPB mediated retroviral cDNA degradation coincides with entry to the nucleus.

Kristine E Yoder1, William Roddick, Pia Hoellerbauer, Richard Fishel.   

Abstract

Retroviruses must integrate their cDNA to a host chromosome, but a significant fraction of retroviral cDNA is degraded before integration. XPB and XPD are part of the TFIIH complex which mediates basal transcription and DNA nucleotide excision repair. Retroviral infection increases when XPB or XPD are mutant. Here we show that inhibition of mRNA or protein synthesis does not affect HIV cDNA accumulation suggesting that TFIIH transcription activity is not required for degradation. Other host factors implicated in the stability of cDNA are not components of the XPB and XPD degradation pathway. Although an increase of retroviral cDNA in XPB or XPD mutant cells correlates with an increase of integrated provirus, the integration efficiency of pre-integration complexes is unaffected. Finally, HIV and MMLV cDNA degradation appears to coincide with nuclear import. These results suggest that TFIIH mediated cDNA degradation is a nuclear host defense against retroviral infection.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21167544      PMCID: PMC3030651          DOI: 10.1016/j.virol.2010.11.016

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  48 in total

1.  Integration complexes derived from HIV vectors for rapid assays in vitro.

Authors:  M S Hansen; G J Smith; T Kafri; V Molteni; J S Siegel; F D Bushman
Journal:  Nat Biotechnol       Date:  1999-06       Impact factor: 54.908

Review 2.  Retrovirus restriction factors.

Authors:  Stephen P Goff
Journal:  Mol Cell       Date:  2004-12-22       Impact factor: 17.970

Review 3.  ERCC2 /XPD gene polymorphisms and lung cancer: a HuGE review.

Authors:  Simone Benhamou; Alain Sarasin
Journal:  Am J Epidemiol       Date:  2005-01-01       Impact factor: 4.897

4.  Antiviral activity of the proteasome on incoming human immunodeficiency virus type 1.

Authors:  O Schwartz; V Maréchal; B Friguet; F Arenzana-Seisdedos; J M Heard
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

5.  Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition.

Authors:  M D Miller; C M Farnet; F D Bushman
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

6.  The relative expression of mutated XPB genes results in xeroderma pigmentosum/Cockayne's syndrome or trichothiodystrophy cellular phenotypes.

Authors:  L Riou; L Zeng; O Chevallier-Lagente; A Stary; O Nikaido; A Taïeb; G Weeda; M Mezzina; A Sarasin
Journal:  Hum Mol Genet       Date:  1999-06       Impact factor: 6.150

7.  Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells.

Authors:  Ya-Lin Chiu; Vanessa B Soros; Jason F Kreisberg; Kim Stopak; Wes Yonemoto; Warner C Greene
Journal:  Nature       Date:  2005-04-13       Impact factor: 49.962

8.  Cell cycle arrest in G2/M promotes early steps of infection by human immunodeficiency virus.

Authors:  Bettina Groschel; Frederic Bushman
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

9.  Impact of ERCC2 gene polymorphism on HIV-1 disease progression to AIDS among North Indian HIV patients.

Authors:  Ranbir Chander Sobti; Nega Berhane; Salih Abdul Mahdi; Rupinder Kler; Seyed Ali Hosseini; Vijish Kuttiat; Ajay Wanchu
Journal:  Mol Biol Rep       Date:  2010-02-02       Impact factor: 2.316

10.  Class II integrase mutants with changes in putative nuclear localization signals are primarily blocked at a postnuclear entry step of human immunodeficiency virus type 1 replication.

Authors:  Richard Lu; Ana Limón; Eric Devroe; Pamela A Silver; Peter Cherepanov; Alan Engelman
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

View more
  8 in total

1.  Evaluation of a system to screen for stimulators of non-specific DNA nicking by HIV-1 integrase: application to a library of 50,000 compounds.

Authors:  Malgorzata Sudol; Jennifer L Fritz; Melissa Tran; Gavin P Robertson; Julie B Ealy; Michael Katzman
Journal:  Antivir Chem Chemother       Date:  2011-10-07

2.  Specific Inhibition of HIV Infection by the Action of Spironolactone in T Cells.

Authors:  Benoît Lacombe; Marina Morel; Florence Margottin-Goguet; Bertha Cecilia Ramirez
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

Review 3.  From promoting to inhibiting: diverse roles of helicases in HIV-1 Replication.

Authors:  Rene-Pierre Lorgeoux; Fei Guo; Chen Liang
Journal:  Retrovirology       Date:  2012-09-28       Impact factor: 4.602

Review 4.  The role of unintegrated DNA in HIV infection.

Authors:  Richard D Sloan; Mark A Wainberg
Journal:  Retrovirology       Date:  2011-07-01       Impact factor: 4.602

Review 5.  The essential and multifunctional TFIIH complex.

Authors:  Jenna K Rimel; Dylan J Taatjes
Journal:  Protein Sci       Date:  2018-04-27       Impact factor: 6.725

6.  LEDGF/p75 Deficiency Increases Deletions at the HIV-1 cDNA Ends.

Authors:  Murilo T D Bueno; Daniel Reyes; Manuel Llano
Journal:  Viruses       Date:  2017-09-15       Impact factor: 5.048

Review 7.  Strategies for Targeting Retroviral Integration for Safer Gene Therapy: Advances and Challenges.

Authors:  Kristine E Yoder; Anthony J Rabe; Richard Fishel; Ross C Larue
Journal:  Front Mol Biosci       Date:  2021-05-12

Review 8.  Spironolactone and XPB: An Old Drug with a New Molecular Target.

Authors:  Ryan D Gabbard; Robert R Hoopes; Michael G Kemp
Journal:  Biomolecules       Date:  2020-05-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.